Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate

Accessed on 1 Apr 2014 from http://www.synthon.com/Corporate/News/PressReleases/Synthon-announces-successful-outcome-of-the-PhaseIII-GATE-study-with-its-generic-glatiramer-acetate?sc_lang=en.